Retatrutide attacks both sides aggressively
Greenfield EA (2019) Administering anesthesia to mice, rats, and hamsters
Risks of potency loss due to improper storage Improper storage leads to several problematic outcomes beyond mere potency reduction
Domestic US travel: Prescription peptides: Carry prescription, keep in original packaging Research peptides: No specific laws against, but recommend discrete packaging International travel: Prescription peptides: Bring prescription, declare at customs Research peptides: Risk of seizure at customs, laws vary by destination country Recommendation: Don't travel internationally with research peptides (high seizure risk) TSA: Allows peptides in carry-on with syringes for medical use
Clinical trials suggest Zepbound causes gastrointestinal side effects slightly more frequently than Wegovy, likely due to its dual-receptor action, but the differences arent dramatic
Most patients begin experiencing weight loss within 24 weeks of starting GLP-1 medications, though the rate varies considerably